£120m Innovation Package Launched for London Life Sciences

Mayor of London Sadiq Khan has announced a £22m public funding allocation. It will unlock over £98m in private and institutional match funding. This will deliver a £120m innovation package across the capital.

The funding was launched to mark the opening of London Life Sciences Week 2026. Furthermore, it is delivered through London’s Local Innovation Partnerships Fund (backed by UKRI). Additionally, it targets three high-growth initiatives spanning cardiometabolic health, healthtech scaling, and quantum computing.

Driving Commercial Scale and NHS Cost Savings

A core focus of the package is bridging the gap between clinical validation and commercial adoption for UK healthtech SMEs:

  • Cardiometabolic Innovation: Accelerates early detection technologies and treatments for heart disease. Specifically, projected to save the NHS £46m in hypertension management alone.
  • Scaling Health Innovation Across London: Provides dedicated infrastructure to help businesses test, validate, and scale diagnostic and monitoring tools across real-world healthcare settings.
  • Expanding the London Quantum Cluster: Backs commercial innovation space around Euston. This is alongside industry giants including IBM, Nvidia, Quantinuum, Amazon, Lendlease, and Canary Wharf Group.

What People Say About The Funding

Mayor of London, Sadiq Khan said: “I’m delighted to announce another major step forward. Through the Local Innovation Partnerships Fund, we’re providing a new shot in the arm for London’s life sciences sector, by investing £22m into three innovative projects. Our commitment has also helped unlock nearly £100m in match funding, sparking a chain reaction of investment that will create jobs, drive growth and fast-track innovation.”

Professor Sir Ian Chapman, UKRI Chief Executive, said: “UKRI is supporting local partnerships right across the UK to build on their distinctive strengths, translating innovation into impact that advances knowledge, improves lives and drives growth.”

Laura Citron OBE, CEO of London & Partners and Chair of the Frontier Innovation Board, said: “London is full of brilliant ideas and talented people. Helping those ideas succeed here has the potential to make life better for Londoners, but it also means creating exciting careers, especially in new industries like quantum.”

Preventing Cardiovascular Disease 

Professor Kevin Fenton, Regional Director of Public Health, NHS London and OHID London, said: “Preventing cardiovascular disease (CVD) is one of London’s biggest public health priorities. Achieving our ambitions will require new ideas, stronger partnerships and faster adoption of proven innovations. These two complementary proposals connect research, venture development, clinical testing and NHS implementation, helping promising discoveries reach the people and communities who need them most.”

Professor Geraint Rees, UCL Vice-Provost (Research, Innovation and Global Engagement), said: “Universities are at the heart of the quantum revolution, creating the discoveries and talent from which new technologies and companies emerge. This investment will connect London’s world-class university research more closely with industry and investors, helping quantum technologies move out of the laboratory, scale in London and deliver benefits across the economy.”

Professor Shitij Kapur, Vice-Chancellor & President of King’s College London, said: “The Local Innovation Partnership Fund has been instrumental in enabling this initiative. By combining King’s research excellence and facilities with the BioInnovation Institute’s venture-building expertise, we can accelerate the translation of discoveries into new therapies and successful businesses, ultimately benefiting patients and society.”

Aiding New Technologies

Mark Kildea, CEO of the Harley Street Health District said: “London’s independent healthcare sector can help promising technologies fulfil their potential. Many clinicians work across public and private healthcare, creating natural routes for expertise and innovation to spread. In helping innovative businesses succeed, we will improve care for patients, create jobs for local people, and help drive London’s economic growth.”

Professor Mary Ryan, Vice Provost Research and Enterprise, Imperial College London, said: “We have seen first hand, through the WestTech London ecosystem, the power of bringing together higher education, the public sector and industry to turn research excellence into breakthroughs and businesses which create jobs, drive growth and improve people’s lives. What starts here in London, though the work of the London Quantum Cluster and the other LIPF projects, will impact the local and national innovation economy.”

Key Takeaways for Growth Hub Readers

  • Public-Private Co-Investment Power: Every £1 of public funding in this package leverages more than £4 in private match funding, illustrating the appetite for commercial R&D partnerships.
  • Clear Commercialisation Pathways for SMEs: Dedicated testbeds allow healthtech and B2B technology firms to generate the clinical and operational ROI evidence required to win major NHS and enterprise contracts.
  • Cluster Effects Around Euston: Concentrated investment in commercial lab and quantum space creates vibrant B2B ecosystems for regional service providers and tech suppliers.

Join hundreds of UK commercial directors, founders, and sales leaders at the National Sales Conference and Awards on 21 January 2027 in Birmingham. Gain practical playbooks on scaling B2B revenue, navigating complex enterprise deals, and celebrating this year’s shortlisted commercial teams.

👉 Explore the Agenda and Book Your Pass for the National Sales Conference

RECOMMENDED FOR YOU

4 Ways to Provide Value to Customers

Businesses today have an onus on them to differentiate themselves amid the increasingly competitive industry landscape. As more and more businesses come and go...

Nick Wealthall – Avoiding the Courtesy Trap

In this video, Nick Wealthall will be sharing some valuable insights on a common challenge we all face in sales: mistaking courtesy for consent....

UK Employers Plan Permanent & Contract Hiring Surge

Over one-third of UK employers plan to increase permanent hiring. Read Robert Half's latest B2B recruitment analysis.
- Advertisment -

FEATURED